An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...

Cancer researchers are one step closer to developing an effective vaccine to treat people with clear cell renal cell ...

Researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a successful anti-cancer immune ...

In a small clinical trial of nine patients with stage III and IV kidney cancer, a personalized anti-tumor vaccine generated ...

A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

All patients involved in the phase 1 trial of a personalized cancer vaccine for high-risk stage III/IV kidney cancer showed a ...

A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...

Dana-Farber Cancer Institute researchers report that all nine patients in a clinical trial being treated for stage III or IV clear cell renal cell carcinoma (a form of kidney cancer), generated a ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate ... to historical controls like anti-PD-1/PD-L1 and anti-CTLA4 ...